Multiple Developments in AstraZeneca’s 340B Contract Pharmacy Lawsuit

The plain language of the 340B statute “explicitly requires drug manufacturers to offer 340B discounts to 340B covered entities regardless of whether the drugs are dispensed by the entity or by an outside pharmacy with which the entity has a contract,” six hospital groups told a federal district judge on Tuesday. The groups did so in a friend of the court brief filed in drug maker AstraZeneca’s lawsuit against the government over 340B contract pharmacy requirements.